Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056844-06
Application #
2097631
Study Section
Special Emphasis Panel (ZRG7-SSS-1 (01))
Program Officer
Erickson, Burdette (BUD) W
Project Start
1991-08-15
Project End
1997-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
6
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Harvard University
Department
Biostatistics & Other Math Sci
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Chuang, S K; Tian, L; Wei, L J et al. (2002) Predicting dental implant survival by use of the marginal approach of the semi-parametric survival methods for clustered observations. J Dent Res 81:851-5
Chuang, S K; Wei, L J; Douglass, C W et al. (2002) Risk factors for dental implant failure: a strategy for the analysis of clustered failure-time observations. J Dent Res 81:572-7
Gilbert, Peter B; Wei, L J; Kosorok, Michael R et al. (2002) Simultaneous inferences on the contrast of two hazard functions with censored observations. Biometrics 58:773-80
Chuang, S K; Tian, L; Wei, L J et al. (2001) Kaplan-Meier analysis of dental implant survival: a strategy for estimating survival with clustered observations. J Dent Res 80:2016-20
Xu, X; Palmer, L J; Horvath, S et al. (2001) Combining multiple phenotypic traits optimally for detecting linkage with sib-pair observations. Genet Epidemiol 21 Suppl 1:S479-83
Cheng, S C; Fine, J P; Wei, L J (1998) Prediction of cumulative incidence function under the proportional hazards model. Biometrics 54:219-28
Betensky, R A (1997) Conditional power calculations for early acceptance of H0 embedded in sequential tests. Stat Med 16:465-77
Betensky, R A (1997) Early stopping to accept H(o) based on conditional power: approximations and comparisons. Biometrics 53:794-806
Zackin, R; Wei, L J (1997) Analysis of repeated virological measurements based on cell dilution assays. Stat Med 16:571-82
Yao, Q; Wei, L J (1996) Play the winner for phase II/III clinical trials. Stat Med 15:2413-23;discussion 2455-8

Showing the most recent 10 out of 12 publications